55390-135 : Floxuridine 500 mg/5ml Intra-arterial Injection, Powder, Lyophilized, for Solution


NDC: 55390-135
Labeler: Bedford Laboratories
Product Type: Human Prescription Drug
Drug Name:  Floxuridine
Dosage Form: Intra-arterial Injection, Powder, Lyophilized, for Solution
Application #: ANDA075387
Rev. Date: 


NDC Package Codes:

  • 55390-135-01: 1 VIAL IN 1 BOX, UNIT‑DOSE (55390‑135‑01) > 5 ML IN 1 VIAL

Active Ingredients:

  • Floxuridine

Dosage Strength:

  • 500 mg/5mL

Pharmaceutical Classes:

  • Antimetabolite [EPC]
  • Deoxyuridine [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 0143-9270 Floxuridine 100 mg/ml Intra-arterial Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 63323-145 Floxuridine 500 mg/5ml Intra-arterial Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
  • 81643-9270 Floxuridine 500 mg Intra-arterial Injection, Powder, Lyophilized, for Solution by Cerona Therapeutics, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55390-135 QR Code

< Prev: 55390-134Next: 55390-136 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.